Ad
related to: novavax vaccine
Search results
Better Buy: Inovio Pharmaceuticals vs. Novavax | The Motley Fool
The Motley Fool· 13 hours agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of...
3 Things You Need to Know If You Buy Novavax Today | The Motley Fool
The Motley Fool· 17 hours agoNovavax (NVAX 5.30%) stock has both soared and plummeted at times in recent years. Investors...
Why Novavax (NVAX) Stock Price Appreciated 14% on Monday
Zacks via Yahoo Finance· 2 days agoNovavax (NVAX) surges after one of its top shareholders drops a proxy campaign against the company....
Moderna, CureVac, other vaccine stocks jump as new human bird-flu cases reported in U.S., Australia
Market Watch· 8 hours agoVaccine-related stocks moved sharply higher Wednesday as new human bird-flu cases were reported in...
Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb - Moderna (NASDAQ:MRNA)
Benzinga· 8 hours agoAccording to a report from NBC News, experts predict a small rise in COVID-19 cases as a newly...
Bird Flu Cases Spur Retail Trader Rush Into Vaccine Stocks
Bloomberg via Yahoo Finance· 6 hours ago(Bloomberg) -- Mounting cases of bird flu in humans is luring the day trading crowd to snap up stock...
Moderna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine
Barrons.com· 5 hours agoOther vaccine stocks are climbing as well. Shares of CureVac which, like Moderna, develops messenger...
COVID’s New ‘FLiRT’ Variants—What To Know As Experts Fear Summer Surge
Forbes· 22 hours agoNew coronavirus variants dubbed “FLiRT” are circulating the world and growing dominant in the U.S.,...
If You'd Invested $10,000 in Novavax a Year Ago, This Is How Much You'd Have Now | The Motley Fool
The Motley Fool· 7 days agoIf you'd invested $10,000 in Novavax (NVAX 9.26%) a year ago, you would have made a risky bet. Prior...
Pfizer plans to cut costs by $1.5 billion as demand for COVID vaccine dwindles
Quartz· 6 hours agoPharma giant Pfizer announced Wednesday another cost-cutting initiative as the company struggles...